These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27824156)

  • 1. Genomic and transcriptomic profiling of resistant CEM/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistance.
    Kadioglu O; Cao J; Kosyakova N; Mrasek K; Liehr T; Efferth T
    Sci Rep; 2016 Nov; 6():36754. PubMed ID: 27824156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential novel drug resistance mechanisms by genomic and transcriptomic profiling of colon cancer cells with p53 deletion.
    Kadioglu O; Saeed M; Mahmoud N; Azawi S; Mrasek K; Liehr T; Efferth T
    Arch Toxicol; 2021 Mar; 95(3):959-974. PubMed ID: 33515271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitensidine A, a guanidine alkaloid from Pterogyne nitens, is a novel substrate for human ABC transporter ABCB1.
    Tajima Y; Nakagawa H; Tamura A; Kadioglu O; Satake K; Mitani Y; Murase H; Regasini LO; Bolzani Vda S; Ishikawa T; Fricker G; Efferth T
    Phytomedicine; 2014 Feb; 21(3):323-32. PubMed ID: 24135452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of P-glycoprotein activity by novel synthetic curcumin derivatives in sensitive and multidrug-resistant T-cell acute lymphoblastic leukemia cell lines.
    Ooko E; Alsalim T; Saeed B; Saeed MEM; Kadioglu O; Abbo HS; Titinchi SJJ; Efferth T
    Toxicol Appl Pharmacol; 2016 Aug; 305():216-233. PubMed ID: 27318188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic imbalances in drug-resistant T-cell acute lymphoblastic CEM leukemia cell lines.
    Efferth T; Verdorfer I; Miyachi H; Sauerbrey A; Drexler HG; Chitambar CR; Haber M; Gebhart E
    Blood Cells Mol Dis; 2002; 29(1):1-13. PubMed ID: 12482398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel drug resistance mechanisms by genomic and transcriptomic profiling of glioblastoma cells with mutation-activated EGFR.
    Kadioglu O; Saeed MEM; Mahmoud N; Azawi S; Mrasek K; Liehr T; Efferth T
    Life Sci; 2021 Nov; 284():119601. PubMed ID: 33991550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine.
    Peng XX; Shi Z; Damaraju VL; Huang XC; Kruh GD; Wu HC; Zhou Y; Tiwari A; Fu L; Cass CE; Chen ZS
    Leuk Res; 2008 May; 32(5):799-809. PubMed ID: 17996297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells.
    Efferth T; Davey M; Olbrich A; Rücker G; Gebhart E; Davey R
    Blood Cells Mol Dis; 2002; 28(2):160-8. PubMed ID: 12064912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and karyotypic characterization of two doxorubicin resistant cell lines isolated from the same parental human leukemia cell line.
    Zalcberg JR; Hu XF; Wall DM; Mirski S; Cole S; Nadalin G; De Luise M; Parkin JD; Vrazas V; Campbell L
    Int J Cancer; 1994 May; 57(4):522-8. PubMed ID: 7514153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter methylation patterns of ABCB1, ABCC1 and ABCG2 in human cancer cell lines, multidrug-resistant cell models and tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.
    Spitzwieser M; Pirker C; Koblmüller B; Pfeiler G; Hacker S; Berger W; Heffeter P; Cichna-Markl M
    Oncotarget; 2016 Nov; 7(45):73347-73369. PubMed ID: 27689338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.
    Svirnovski AI; Shman TV; Serhiyenka TF; Savitski VP; Smolnikova VV; Fedasenka UU
    Hematology; 2009 Aug; 14(4):204-12. PubMed ID: 19635183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-expression profiling reveals down-regulation of equilibrative nucleoside transporter 1 (ENT1) in Ara-C-resistant CCRF-CEM-derived cells.
    Takagaki K; Katsuma S; Kaminishi Y; Horio T; Nakagawa S; Tanaka T; Ohgi T; Yano J
    J Biochem; 2004 Nov; 136(5):733-40. PubMed ID: 15632314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
    Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
    Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oleanolic acid derivative methyl 3,11-dioxoolean-12-en-28-olate targets multidrug resistance related to ABCB1.
    Paszel A; Rubiś B; Bednarczyk-Cwynar B; Zaprutko L; Kaczmarek M; Hofmann J; Rybczyńska M
    Pharmacol Rep; 2011; 63(6):1500-17. PubMed ID: 22358098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking.
    Saeed M; Kuete V; Kadioglu O; Börtzler J; Khalid H; Greten HJ; Efferth T
    Phytomedicine; 2014 Oct; 21(12):1525-33. PubMed ID: 25442261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel selection and genetic characterisation of an etoposide-resistant human leukaemic CCRF-CEM cell line.
    Patel S; Fisher LM
    Br J Cancer; 1993 Mar; 67(3):456-63. PubMed ID: 8382508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulations of ABCB1 and ABCG2 expression through MAPK pathways in acute lymphoblastic leukemia cell lines.
    Tomiyasu H; Watanabe M; Sugita K; Goto-Koshino Y; Fujino Y; Ohno K; Sugano S; Tsujimoto H
    Anticancer Res; 2013 Dec; 33(12):5317-23. PubMed ID: 24324065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity of novel sulfanilamides towards sensitive and multidrug-resistant leukemia cells.
    AlSalim T; Saeed ME; Hadi JS; Zeino M; Gany R; Kadioglu O; Titinchi SJ; Abbo HS; Efferth T
    Curr Med Chem; 2014; 21(23):2715-25. PubMed ID: 24438524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cytogenetic characterization of drug-resistant leukemia cell lines by comparative genomic hybridization and fluorescence in situ hybridization.
    Shimizu H; Fukuda T; Ghazizadeh M; Nagashima M; Kawanami O; Suzuki T
    Jpn J Cancer Res; 2002 Aug; 93(8):902-10. PubMed ID: 12716468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative M-FISH and CGH analyses in sensitive and drug-resistant human T-cell acute leukemia cell lines.
    Weise A; Liehr T; Efferth T; Kuechler A; Gebhart E
    Cytogenet Genome Res; 2002; 98(2-3):118-25. PubMed ID: 12697993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.